CRP and COVID-19: In the present study, we investigated serial PCT and CRP levels in critically ill COVID-19 patients treated with dexamethasone only or in combination with tocilizumab, and compared the natural course and accuracy to detect bacterial infections to the data obtained from patients that did not receive these immunomodulatory treatments [5].